Animal vaccine adjuvant trends are increasingly shaped by the growing demand for safer formulations, improved immune performance and more flexible vaccination methods.

As a practitioner in the animal vaccine adjuvant industry, having witnessed the evolution of adjuvant technologies from basic formulations to more advanced and specialized solutions, I would like to share some personal perspectives on the future development trends of animal vaccines and adjuvants.

Currently, animal vaccine adjuvants are mainly used in inactivated vaccines or as diluents for live vaccines.

For live vaccines, due to their inherent characteristics, the requirements for adjuvants are generally focused on whether they are suitable for administration methods such as nasal drops, eye drops, or vaccine reconstitution.

Therefore, this article mainly focuses on the future development of adjuvants for inactivated vaccines.

---

1. Current Application Forms of Animal Vaccine Adjuvants

At present, adjuvants used in inactivated vaccines can generally be classified into several major types:

• Oil-in-water (O/W) adjuvants
• Water-in-oil (W/O) adjuvants
• Double emulsion (W/O/W) adjuvants
• Water-based adjuvants (polymer adjuvants)

In addition, aluminum hydroxide adjuvants and aluminum phosphate adjuvants are also used in certain vaccine applications, although their application range is relatively narrower compared with the above categories.

Oil-in-Water (O/W) Adjuvants

As the name suggests, oil-in-water adjuvants consist of an oil phase dispersed within a continuous water phase.

Their main function is to provide controlled release of antigens in the body and enhance immune responses.

O/W adjuvants are widely used in livestock vaccine production, with typical addition ratios generally ranging from 10% to 20%, while the remaining formulation consists mainly of the antigen-containing aqueous phase.

Water-in-Oil (W/O) Adjuvants

Water-in-oil adjuvants usually contain a higher proportion of oil phase, commonly around 60%–70%.

They are widely used in poultry vaccines, especially in situations where bacterial vaccine stability needs to be improved.

Due to their strong stability characteristics, W/O adjuvants can effectively enhance vaccine persistence.

However, their application in livestock vaccines requires careful consideration. Since livestock animals are mammals, they may be more sensitive to oil-based components and injection stimulation.

If the formulation quality is not properly controlled, potential adverse reactions may occur, including fever, reduced appetite, lethargy, or other stress responses.

Therefore, formulation safety and compatibility are critical factors when developing W/O adjuvants.

Double Emulsion (W/O/W) Adjuvants

Double emulsion adjuvants contain both oil and water phases, forming a water-in-oil-in-water structure.

This type of adjuvant is widely used in foot-and-mouth disease vaccines and has also been applied in other livestock vaccine products.

Water-Based Adjuvants (Polymer Adjuvants)

Water-based adjuvants, also known as polymer adjuvants, typically contain materials such as:

• Chitosan
• Carbomer
• Other functional polymer materials

Because they do not contain oil components, vaccines formulated with water-based adjuvants generally do not present the traditional milky-white appearance associated with oil emulsions.

Some water-based adjuvant products may show different colors depending on their formulation characteristics.

---

2. Future Development Directions of Vaccine Adjuvants

Water-Based Adjuvants (Polymer Adjuvants)

With increasing competition in the animal vaccine industry, especially in livestock vaccines, end users are placing higher demands on vaccine safety.

Due to the absence of oil components, water-based adjuvants can help reduce the possibility of injection-related adverse reactions while maintaining immune enhancement performance.

These advantages have contributed to their increasing acceptance in the market.

Representative products include the GEL series developed by SEPPIC and ADJ 800 series products developed by ADJ Bio, which are designed to provide safe and effective adjuvant solutions.

Water-Based Adjuvants as Immune Enhancers

In some vaccine production strategies, manufacturers have begun exploring formulations without traditional adjuvants, instead using immune-enhancing agents to improve vaccine safety profiles.

In certain applications, the addition level of such immune enhancers can be extremely low, sometimes reaching only several parts per ten thousand, while commonly remaining below 0.5%.

This direction represents another important area of future exploration for vaccine formulation technology.

---

3. Future Trends in Immunization Methods

Oral Immunization

Some water-based adjuvants, due to their unique biological and formulation properties, have demonstrated potential for oral immunization approaches.

Developing effective oral vaccine delivery systems remains an active research area within the industry.

Needle-Free Injection

Needle-free injection technologies require vaccine formulations with specific particle size and physical stability characteristics.

Because oil emulsion adjuvants generally have larger dispersed particle structures, they may face limitations in certain needle-free injection applications.

Similarly, some bacterial vaccines with larger particle sizes may also require further optimization before being suitable for these technologies.

Combination Vaccination: Multiple Protections with One Injection

To reduce potential infection risks and stress caused by repeated injections, vaccine manufacturers are increasingly exploring combination vaccination strategies.

These approaches include:

• Mixing compatible vaccines before administration
• Using inactivated vaccines to dilute live vaccines for injection
• Using inactivated vaccine formulations as carriers for simultaneously administered biological products

Such strategies place new demands on vaccine compatibility, stability, and adjuvant performance.

---

Conclusion

The future development of animal vaccine technologies will continue to create new requirements for adjuvant systems.

Emerging trends such as safer formulations, water-based adjuvants, needle-free delivery, oral immunization, and combination vaccination will drive continuous innovation in adjuvant development.

As a professional animal vaccine adjuvant developer, ADJ Bio welcomes technical discussions and cooperation with industry partners worldwide.

By focusing on innovation and advancing animal health technologies, we aim to contribute to the future development of the livestock industry.

---

Technical Note

This article is based on industry experience and technical observations. Actual vaccine formulation selection and application should be evaluated according to specific antigen characteristics, production processes, regulatory requirements, and animal testing results.